{
    "clinical_study": {
        "@rank": "13539", 
        "brief_summary": {
            "textblock": "A double-blind, randomized, dose-response study of four dilutions of Dryvax in previously\n      vaccinated adults in order to assess the clinical success rates, humoral responses, and\n      virus-specific actifity of cytotoxi T cells and interferon-y producing T cells"
        }, 
        "brief_title": "Dryvax Dilution-Prev Vacc Adults", 
        "completion_date": "November 2004", 
        "condition": "Smallpox", 
        "condition_browse": {
            "mesh_term": "Smallpox"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  For cohort E (never vaccinated): Aged 18-31; Never been vaccinated for smallpox.\n\n          -  If female, not pregnant or lactating.\n\n          -  Promise to use an effective method of birth control for 7 months after vaccination.\n\n          -  Negative result on a test for HIV, AIDS, Hepatitis B and C.\n\n          -  Acceptable as blood donors.\n\n          -  For cohorts A, B, C, D (previously vaccinated): Aged 32 to 60 years; known history of\n             smallpox vaccination with a typical vaccinia scar; no smallpox vaccination after\n             1971.\n\n          -  Healthy adults (aged 18-60).\n\n        Exclusion Criteria:\n\n          -  Eczema or history of eczema, or other chronic skin disorder.\n\n          -  Pregnancy or lactation.\n\n          -  History of immunodeficiency, liver disease, severe kidney impairment, malignancy,\n             HIV, Hepatitis B, or Hepatitis C.\n\n          -  Household contact with persons who are under 12 months of age, pregnant or lactating,\n             or have any of the specified diseases."
            }, 
            "gender": "Both", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "90", 
        "firstreceived_date": "March 28, 2002", 
        "id_info": {
            "nct_id": "NCT00032708", 
            "org_study_id": "01-651"
        }, 
        "intervention": {
            "intervention_name": "Dryvax", 
            "intervention_type": "Biological"
        }, 
        "lastchanged_date": "August 26, 2010", 
        "location": {
            "facility": {
                "address": {
                    "city": "St. Louis", 
                    "country": "United States", 
                    "state": "Missouri", 
                    "zip": "63110-0250"
                }, 
                "name": "Saint Louis University Health Sciences Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Double Blind, Randomized Dose Response Study of Dryvax Vaccine Against Smallpox in Previously Vaccinated Adults", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00032708"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "April 2004", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2006"
    }, 
    "geocoordinates": {
        "Saint Louis University Health Sciences Center": "38.627 -90.199"
    }
}